US Stock MarketDetailed Quotes

HAO Haoxi Health Technology

Watchlist
  • 0.131
  • +0.001+1.08%
Close Nov 29 13:00 ET
  • 0.130
  • -0.001-1.07%
Post 17:02 ET
6.60MMarket Cap3.29P/E (TTM)

Haoxi Health Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.28%-747.58K
-29.14%-872.13K
-127.36%-675.36K
2.47M
Net income from continuing operations
33.20%1.29M
296.49%969.75K
-19.56%244.59K
--304.07K
Operating gains losses
----
----
----
--10.12K
Depreciation and amortization
25.90%10.57K
279.43%8.39K
438.20%2.21K
--411
Other non cash items
----
----
----
--180.62K
Change In working capital
-10.78%-2.05M
-100.65%-1.85M
-142.82%-922.16K
--2.15M
-Change in receivables
-4,992.31%-217.9K
-100.64%-4.28K
325.43%665.62K
---295.26K
-Change in prepaid assets
-19.73%-2.9M
-641.06%-2.42M
178.33%447.51K
---571.32K
-Change in payables and accrued expense
266.06%1.4M
49.65%-840.24K
-159.68%-1.67M
--2.8M
-Change in other current assets
-1,086.36%-90.38K
-108.43%-7.62K
179.46%90.41K
---113.79K
-Change in other current liabilities
207.38%90.38K
133.53%29.4K
5.00%-87.69K
---92.3K
-Change in other working capital
-123.54%-328.08K
477.49%1.39M
-185.84%-369.22K
--430.14K
Cash from discontinued investing activities
Operating cash flow
14.28%-747.58K
-29.14%-872.13K
-125.50%-675.36K
--2.65M
Investing cash flow
Cash flow from continuing investing activities
-6,777.04%-3.13M
-423.11%-45.5K
-166.65%-8.7K
-3.26K
Net PPE purchase and sale
-21.69%-55.37K
-423.11%-45.5K
-166.65%-8.7K
---3.26K
Net other investing changes
---3.07M
----
----
----
Cash from discontinued investing activities
Investing cash flow
-6,777.04%-3.13M
-423.11%-45.5K
-166.65%-8.7K
---3.26K
Financing cash flow
Cash flow from continuing financing activities
417.24%9.32M
93.16%1.8M
135.72%933.22K
-2.61M
Net issuance payments of debt
-1.19%362.47K
32.04%366.83K
120.68%277.81K
---1.34M
Net common stock issuance
350.06%8.98M
1,116.60%1.99M
--163.92K
----
Net other financing activities
97.43%-14.33K
-213.64%-558.52K
138.72%491.49K
---1.27M
Cash from discontinued financing activities
Financing cash flow
417.24%9.32M
93.16%1.8M
135.72%933.22K
---2.61M
Net cash flow
Beginning cash position
309.93%1.2M
425.20%293.51K
174.89%55.89K
--20.33K
Current changes in cash
515.52%5.45M
255.17%884.94K
660.44%249.16K
--32.77K
Effect of exchange rate changes
-77.38%5.6K
314.63%24.76K
-513.26%-11.53K
--2.79K
End cash Position
453.17%6.66M
309.93%1.2M
425.20%293.51K
--55.89K
Free cash flow
12.50%-802.94K
-34.15%-917.63K
-125.86%-684.06K
--2.65M
Currency Unit
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.28%-747.58K-29.14%-872.13K-127.36%-675.36K2.47M
Net income from continuing operations 33.20%1.29M296.49%969.75K-19.56%244.59K--304.07K
Operating gains losses --------------10.12K
Depreciation and amortization 25.90%10.57K279.43%8.39K438.20%2.21K--411
Other non cash items --------------180.62K
Change In working capital -10.78%-2.05M-100.65%-1.85M-142.82%-922.16K--2.15M
-Change in receivables -4,992.31%-217.9K-100.64%-4.28K325.43%665.62K---295.26K
-Change in prepaid assets -19.73%-2.9M-641.06%-2.42M178.33%447.51K---571.32K
-Change in payables and accrued expense 266.06%1.4M49.65%-840.24K-159.68%-1.67M--2.8M
-Change in other current assets -1,086.36%-90.38K-108.43%-7.62K179.46%90.41K---113.79K
-Change in other current liabilities 207.38%90.38K133.53%29.4K5.00%-87.69K---92.3K
-Change in other working capital -123.54%-328.08K477.49%1.39M-185.84%-369.22K--430.14K
Cash from discontinued investing activities
Operating cash flow 14.28%-747.58K-29.14%-872.13K-125.50%-675.36K--2.65M
Investing cash flow
Cash flow from continuing investing activities -6,777.04%-3.13M-423.11%-45.5K-166.65%-8.7K-3.26K
Net PPE purchase and sale -21.69%-55.37K-423.11%-45.5K-166.65%-8.7K---3.26K
Net other investing changes ---3.07M------------
Cash from discontinued investing activities
Investing cash flow -6,777.04%-3.13M-423.11%-45.5K-166.65%-8.7K---3.26K
Financing cash flow
Cash flow from continuing financing activities 417.24%9.32M93.16%1.8M135.72%933.22K-2.61M
Net issuance payments of debt -1.19%362.47K32.04%366.83K120.68%277.81K---1.34M
Net common stock issuance 350.06%8.98M1,116.60%1.99M--163.92K----
Net other financing activities 97.43%-14.33K-213.64%-558.52K138.72%491.49K---1.27M
Cash from discontinued financing activities
Financing cash flow 417.24%9.32M93.16%1.8M135.72%933.22K---2.61M
Net cash flow
Beginning cash position 309.93%1.2M425.20%293.51K174.89%55.89K--20.33K
Current changes in cash 515.52%5.45M255.17%884.94K660.44%249.16K--32.77K
Effect of exchange rate changes -77.38%5.6K314.63%24.76K-513.26%-11.53K--2.79K
End cash Position 453.17%6.66M309.93%1.2M425.20%293.51K--55.89K
Free cash flow 12.50%-802.94K-34.15%-917.63K-125.86%-684.06K--2.65M
Currency Unit USDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data